New study aims to better classify small newborns for tailored nutrition

NCT ID NCT07483424

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 290 full-term babies who were small at birth due to intrauterine growth restriction (IUGR). Researchers will measure their body fat and muscle using a special machine, and track their growth and feeding for three months. The goal is to find different types of IUGR so doctors can give the right nutritional support to each baby.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better identify which small newborns need special nutrition, leading to more personalized feeding plans.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve health, and results may not apply to all infants with IUGR.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 290 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Full term infants diagnosed with intrauterine growth restriction.

Ages

37 to 41 weeks

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * IUGR and term GA (37+0/7 to 41+6/7 weeks of gestation) Exclusion Criteria: * Eligible fetuses with congenital malformations * Eligible fetuses with genetic mutations. * Eligible infants with congenital malformations * Eligible intants with inborn errors of metabolism. * Infants who become ill and require hospitalization during the study period * Infants who die during the study period * Parents or legal guardians who do not agree to participate * Parents or legal guardians who abandon the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intrauterine growth restriction (IUGR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Unidade Local de Saúde São José

    Lisbon, 1150-199, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.